{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:49Z","timestamp":1740108409829,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10096-023-04555-3","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T14:07:43Z","timestamp":1675260463000},"page":"323-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning\u2013based approach"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-0288","authenticated-orcid":false,"given":"Xiao-Yu","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"issue":"11","key":"4555_CR1","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10096-021-04227-0","volume":"40","author":"L Yang","year":"2021","unstructured":"Yang L, Xia P, Zhou Y, Cui Q, Chen G, Zheng K et al (2021) Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy. Eur J Clin Microbiol Infect Dis 40(11):2305\u20132314","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"4555_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","volume":"96","author":"A Kanj","year":"2021","unstructured":"Kanj A, Samhouri B, Abdallah N, Chehab O, Baqir M (2021) Host factors and outcomes in hospitalizations for Pneumocystis jirovecii pneumonia in the United States. Mayo Clin Proc 96(2):400\u2013407","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"4555_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","volume":"267","author":"KA Sepkowitz","year":"1992","unstructured":"Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267(6):832\u2013837","journal-title":"JAMA"},{"issue":"1","key":"4555_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71(1):5\u201313","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"4555_CR5","doi-asserted-by":"publisher","first-page":"1242 e11","DOI":"10.1016\/j.amjmed.2014.07.010","volume":"127","author":"P Fillatre","year":"2014","unstructured":"Fillatre P, Decaux O, Jouneau S, Revest M, Gacouin A, Robert-Gangneux F et al (2014) Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am J Med 127(12):1242 e11\u20131242 e17","journal-title":"Am J Med"},{"issue":"4","key":"4555_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM et al (2021) Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int 100(4):753\u2013779","journal-title":"Kidney Int"},{"issue":"9","key":"4555_CR7","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1093\/ndt\/gfn161","volume":"23","author":"J Lv","year":"2008","unstructured":"Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H (2008) Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy. Nephrol Dial Transplant 23(9):2868\u20132872","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"4555_CR8","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2169\/internalmedicine.51.6774","volume":"51","author":"CY Yang","year":"2012","unstructured":"Yang CY, Yang AH, Yang WC, Lin CC (2012) Risk factors for Pneumocystis jiroveci pneumonia in glomerulonephritis patients receiving immunosuppressants. Intern Med 51(20):2869\u20132875","journal-title":"Intern Med"},{"issue":"4","key":"4555_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/rheumatology\/keh071","volume":"43","author":"K Saito","year":"2004","unstructured":"Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K et al (2004) Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 43(4):479\u2013485","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4555_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.4065\/82.9.1052","volume":"82","author":"H Green","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82(9):1052\u20131059","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"4555_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/archinte.1995.00430110015002","volume":"155","author":"KA Sepkowitz","year":"1995","unstructured":"Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk. Arch Intern Med 155(11):1125\u20131128","journal-title":"Arch Intern Med"},{"issue":"1","key":"4555_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jinf.2014.02.015","volume":"69","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Lee J, Cho YJ, Park YS, Lee CH, Yoon HI et al (2014) Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection. J Infect 69(1):88\u201395","journal-title":"J Infect"},{"issue":"10","key":"4555_CR13","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1128\/AAC.00669-11","volume":"55","author":"SM Moon","year":"2011","unstructured":"Moon SM, Kim T, Sung H, Kim MN, Kim SH, Choi SH et al (2011) Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients. Antimicrob Agents Chemother 55(10):4613\u20134618","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4555_CR14","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s11255-016-1324-x","volume":"48","author":"WL Ye","year":"2016","unstructured":"Ye WL, Tang N, Wen YB, Li H, Li MX, Du B et al (2016) Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease. Int Urol Nephrol 48(11):1863\u20131871","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"4555_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/00365548.2014.936492","volume":"46","author":"S Leth","year":"2014","unstructured":"Leth S, Jensen-Fangel S, Ostergaard L, Rostved AA, Jespersen B, Sogaard OS (2014) Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population. Scand J Infect Dis 46(10):704\u2013711","journal-title":"Scand J Infect Dis"},{"issue":"3","key":"4555_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","volume":"140","author":"J Chen","year":"2004","unstructured":"Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V et al (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140(3):167\u2013174","journal-title":"Ann Intern Med"},{"issue":"24","key":"4555_CR17","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr","year":"2004","unstructured":"Thomas CF Jr (2004) and A.H. Limper, Pneumocystis pneumonia. N Engl J Med 350(24):2487\u20132498","journal-title":"N Engl J Med"},{"key":"4555_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/IDR.S199761","volume":"12","author":"CJ Liu","year":"2019","unstructured":"Liu CJ, Lee TF, Ruan SY, Yu CJ, Chien JY, Hsueh PR (2019) Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients. Infect Drug Resist 12:1457\u20131467","journal-title":"Infect Drug Resist"},{"key":"4555_CR19","doi-asserted-by":"publisher","first-page":"652383","DOI":"10.3389\/fimmu.2021.652383","volume":"12","author":"G Tang","year":"2021","unstructured":"Tang G, Tong S, Yuan X, Lin Q, Luo Y, Song H et al (2021) Using routine laboratory markers and immunological indicators for predicting Pneumocystis jiroveci pneumonia in immunocompromised patients. Front Immunol 12:652383","journal-title":"Front Immunol"},{"issue":"1","key":"4555_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","volume":"9","author":"BJ Gaborit","year":"2019","unstructured":"Gaborit BJ, Tessoulin B, Lavergne RA, Morio F, Sagan C, Canet E et al (2019) Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study. Ann Intensive Care 9(1):131","journal-title":"Ann Intensive Care"},{"issue":"8","key":"4555_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1159\/000508666","volume":"99","author":"C Elsener","year":"2020","unstructured":"Elsener C, Beeler PE, Battegay E, Bello B, Thienemann F (2020) Risk factors of in-hospital mortality in patients treated for pneumonia at a tertiary care centre in Switzerland. Respiration 99(8):637\u2013645","journal-title":"Respiration"},{"key":"4555_CR22","doi-asserted-by":"crossref","unstructured":"Berrar and Daniel, Cross-validation. Encycl Bioinformat Computat Biol, 2018.","DOI":"10.1016\/B978-0-12-809633-8.20349-X"},{"key":"4555_CR23","unstructured":"Lundberg SM and L. SI., A unified approach to interpreting model predictions. In: NIPS\u201917: Proceedings of the 31st International Conference on Neural Information Processing Systems. (2017). p. 4768\u201377., 2017."},{"issue":"5","key":"4555_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","volume":"77","author":"JW Park","year":"2018","unstructured":"Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB (2018) Prophylactic effect of trimethoprim-sulfamethoxazole for Pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis 77(5):644\u2013649","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4555_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jinf.2005.06.014","volume":"53","author":"L Mikaelsson","year":"2006","unstructured":"Mikaelsson L, Jacobsson G, Andersson R (2006) Pneumocystis pneumonia\u2014a retrospective study 1991\u20132001 in Gothenburg. Sweden. J Infect 53(4):260\u2013265","journal-title":"Sweden. J Infect"},{"key":"4555_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fpubh.2019.00275","volume":"7","author":"E Pereira-Diaz","year":"2019","unstructured":"Pereira-Diaz E, Moreno-Verdejo F, de la Horra C, Guerrero JA, Calderon EJ, Medrano FJ (2019) Changing trends in the epidemiology and risk factors of Pneumocystis pneumonia in Spain. Front Public Health 7:275","journal-title":"Front Public Health"},{"issue":"6","key":"4555_CR27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/ndt\/gfq689","volume":"26","author":"F Eitner","year":"2011","unstructured":"Eitner F, Hauser IA, Rettkowski O, Rath T, Lopau K, Pliquett RU et al (2011) Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients. Nephrol Dial Transplant 26(6):2013\u20132017","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4555_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1378\/chest.128.2.573","volume":"128","author":"E Festic","year":"2005","unstructured":"Festic E, Gajic O, Limper AH, Aksamit TR (2005) Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 128(2):573\u2013579","journal-title":"Chest"},{"issue":"3","key":"4555_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/00365548.2013.865142","volume":"46","author":"F Roblot","year":"2014","unstructured":"Roblot F, Le Moal G, Kauffmann-Lacroix C, Bastides F, Boutoille D, Verdon R et al (2014) Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment. Scand J Infect Dis 46(3):210\u2013214","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"4555_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13075-021-02606-8","volume":"23","author":"L Huang","year":"2021","unstructured":"Huang L, Fu Q, Ye Y, Lin Y, Yan Q, Chen S (2021) High incidence and mortality of Pneumocystis jirovecii infection in anti-MDA5-antibody-positive dermatomyositis: experience from a single center. Arthritis Res Ther 23(1):232","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4555_CR31","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1093\/rheumatology\/keab941","volume":"61","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Huang Y, Ming B, Zhong J, Dong L (2022) Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study. Rheumatology (Oxford) 61(9):3766\u20133776","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"4555_CR32","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1681\/ASN.2016091022","volume":"28","author":"J van den Brand","year":"2017","unstructured":"van den Brand J, Ruggenenti P, Chianca A, Hofstra JM, Perna A, Ruggiero B et al (2017) Safety of Rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy. J Am Soc Nephrol 28(9):2729\u20132737","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4555_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","volume":"24","author":"AB Reid","year":"2011","unstructured":"Reid AB, Chen SC, Worth LJ (2011) Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools. Curr Opin Infect Dis 24(6):534\u2013544","journal-title":"Curr Opin Infect Dis"},{"issue":"24","key":"4555_CR34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","volume":"338","author":"JA Fishman","year":"1998","unstructured":"Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338(24):1741\u20131751","journal-title":"N Engl J Med"},{"issue":"10","key":"4555_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/nep.13544","volume":"24","author":"T Wang","year":"2019","unstructured":"Wang T, Zhang Y, Ping F, Zhao H, Yan L, Lin Q et al (2019) Predicting risk of pulmonary infection in patients with primary membranous nephropathy on immunosuppressive therapy: the AIM-7C score. Nephrology (Carlton) 24(10):1009\u20131016","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"4555_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","volume":"12","author":"J Li","year":"2006","unstructured":"Li J, Huang XM, Fang WG, Zeng XJ (2006) Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12(3):114\u2013117","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"4555_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1378\/chest.118.3.712","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H (2000) Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118(3):712\u2013720","journal-title":"Chest"},{"key":"4555_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijid.2017.02.010","volume":"57","author":"Y Li","year":"2017","unstructured":"Li Y, Ghannoum M, Deng C, Gao Y, Zhu H, Yu X et al (2017) Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping. Int J Infect Dis 57:108\u2013115","journal-title":"Int J Infect Dis"},{"issue":"4","key":"4555_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1681\/ASN.2009080861","volume":"21","author":"N Polanco","year":"2010","unstructured":"Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A et al (2010) Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21(4):697\u2013704","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4555_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CCM.0b013e3181feb46a","volume":"39","author":"J Aman","year":"2011","unstructured":"Aman J, van der Heijden M, van Lingen A, Girbes AR, van Nieuw Amerongen GP, van Hinsbergh VW et al (2011) Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury\/acute respiratory distress syndrome. Crit Care Med 39(1):89\u201397","journal-title":"Crit Care Med"},{"issue":"7","key":"4555_CR41","doi-asserted-by":"publisher","first-page":"e101943","DOI":"10.1371\/journal.pone.0101943","volume":"9","author":"F Guo","year":"2014","unstructured":"Guo F, Chen Y, Yang SL, Xia H, Li XW, Tong ZH (2014) Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China. PLoS One 9(7):e101943","journal-title":"PLoS One"},{"issue":"12","key":"4555_CR42","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/ndt\/14.12.2807","volume":"14","author":"M Girndt","year":"1999","unstructured":"Girndt M, Sester U, Sester M, Kaul H, Kohler H (1999) Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 14(12):2807\u20132810","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4555_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.ki.5001550","volume":"70","author":"JW Yoon","year":"2006","unstructured":"Yoon JW, Gollapudi S, Pahl MV, Vaziri ND (2006) Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 70(2):371\u2013376","journal-title":"Kidney Int"},{"key":"4555_CR44","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1046\/j.1523-1755.2001.59780195.x","volume":"78","author":"S Massry","year":"2001","unstructured":"Massry S, Smogorzewski M (2001) Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone. Kidney Int Suppl 78:S195\u2013S196","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"4555_CR45","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3201\/eid2009.131668","volume":"20","author":"A Roux","year":"2014","unstructured":"Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A et al (2014) Pneumocystis jirovecii pneumonia in patients with or without AIDS. France. Emerg Infect Dis 20(9):1490\u20131497","journal-title":"France. Emerg Infect Dis"},{"issue":"1","key":"4555_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","volume":"47","author":"MC Li","year":"2014","unstructured":"Li MC, Lee NY, Lee CC, Lee HC, Chang CM, Ko WC (2014) Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect 47(1):42\u201347","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"4555_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","volume":"96","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF, Schafer G, Hoenigl M, Gunther G, Hoffmann C, Kalsdorf B et al (2018) Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 96(1):52\u201365","journal-title":"Respiration"},{"key":"4555_CR48","doi-asserted-by":"publisher","first-page":"19906","DOI":"10.7448\/IAS.18.1.19906","volume":"18","author":"A Alvaro-Meca","year":"2015","unstructured":"Alvaro-Meca A, Palomares-Sancho I, Diaz A, Resino R, De Miguel AG, Resino S (2015) Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors. J Int AIDS Soc 18:19906","journal-title":"J Int AIDS Soc"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04555-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04555-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T22:07:42Z","timestamp":1675634862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04555-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["4555"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04555-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of Tongji Hospital. Informed patient consent was waived since the data set of this research consisted of de-identified secondary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors agree to participate in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agree to publish in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}